Anti-VEGF versus dexamethasone implant (Ozurdex) for the management of Centre involved Diabetic Macular Edema (CiDME): a randomized study.

Ashish SharmaKeerthi BellalaPankaj DongrePrahalad Reddy

Published in: International ophthalmology (2019)

Both the groups had the similar visual outcome. However, the superior anatomical result was observed in dexamethasone implant group during this short follow-up.

Keyphrases

high dose
low dose
soft tissue
vascular endothelial growth factor
endothelial cells